These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24749563)

  • 21. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.
    Uduku C; Oliver N
    Curr Opin Pharmacol; 2017 Oct; 36():29-33. PubMed ID: 28802779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closed-loop in children with type 1 diabetes: specific challenges.
    Elleri D; Allen JM; Dunger DB; Hovorkea R
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S131-5. PubMed ID: 21864745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.
    Ly TT; Roy A; Grosman B; Shin J; Campbell A; Monirabbasi S; Liang B; von Eyben R; Shanmugham S; Clinton P; Buckingham BA
    Diabetes Care; 2015 Jul; 38(7):1205-11. PubMed ID: 26049550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multinight "bedside" closed-loop control for patients with type 1 diabetes.
    Brown SA; Kovatchev BP; Breton MD; Anderson SM; Keith-Hynes P; Patek SD; Jiang B; Ben Brahim N; Vereshchetin P; Bruttomesso D; Avogaro A; Del Favero S; Boscari F; Galasso S; Visentin R; Monaro M; Cobelli C
    Diabetes Technol Ther; 2015 Mar; 17(3):203-9. PubMed ID: 25594434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coming of age: the artificial pancreas for type 1 diabetes.
    Thabit H; Hovorka R
    Diabetologia; 2016 Sep; 59(9):1795-805. PubMed ID: 27364997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel insulin delivery profiles for mixed meals for sensor-augmented pump and closed-loop artificial pancreas therapy for type 1 diabetes mellitus.
    Srinivasan A; Lee JB; Dassau E; Doyle FJ
    J Diabetes Sci Technol; 2014 Sep; 8(5):957-68. PubMed ID: 25049364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend.
    Graf A; Ward GM; Vogrin S; Sundararajan V; Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2017 Jul; 19(7):438-439. PubMed ID: 28537427
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
    Schaepelynck P; Darmon P; Molines L; Jannot-Lamotte MF; Treglia C; Raccah D
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S85-93. PubMed ID: 22208717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes.
    Zaharieva DP; Messer LH; Paldus B; O'Neal DN; Maahs DM; Riddell MC
    Can J Diabetes; 2020 Dec; 44(8):740-749. PubMed ID: 33011134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.
    Leelarathna L; Dellweg S; Mader JK; Allen JM; Benesch C; Doll W; Ellmerer M; Hartnell S; Heinemann L; Kojzar H; Michalewski L; Nodale M; Thabit H; Wilinska ME; Pieber TR; Arnolds S; Evans ML; Hovorka R;
    Diabetes Care; 2014 Jul; 37(7):1931-7. PubMed ID: 24963110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.
    Nimri R; Muller I; Atlas E; Miller S; Fogel A; Bratina N; Kordonouri O; Battelino T; Danne T; Phillip M
    Diabetes Care; 2014 Nov; 37(11):3025-32. PubMed ID: 25078901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial Pancreas Project at Cambridge 2013.
    Hovorka R
    Diabet Med; 2015 Aug; 32(8):987-92. PubMed ID: 25819473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.
    Nimri R; Bratina N; Kordonouri O; Avbelj Stefanija M; Fath M; Biester T; Muller I; Atlas E; Miller S; Fogel A; Phillip M; Danne T; Battelino T
    Diabetes Obes Metab; 2017 Apr; 19(4):553-561. PubMed ID: 27981804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Diabet Med; 2010 Apr; 27(4):480-4. PubMed ID: 20536523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
    Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
    Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin pumps: from inception to the present and toward the future.
    Alsaleh FM; Smith FJ; Keady S; Taylor KM
    J Clin Pharm Ther; 2010 Apr; 35(2):127-38. PubMed ID: 20456732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.